Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2002
07/03/2002EP1218360A1 Triazine kinase inhibitors
07/03/2002EP1218359A2 Piperazine compounds
07/03/2002EP1218358A1 Therapeutic quinazoline compounds
07/03/2002EP1218357A1 Quinazoline derivatives
07/03/2002EP1218356A1 Quinazoline compounds and pharmaceutical compositions containing them
07/03/2002EP1218355A1 Therapeutic quinazoline derivatives
07/03/2002EP1218354A1 Quinazoline derivatives and their use as pharmaceuticals
07/03/2002EP1218353A1 Quinazoline derivatives
07/03/2002EP1218350A1 1-aryl-1,3-dihydro-imidazol-2-(thi)one derivatives, production of said compound and use as a dessicating/defoliating agent for plants
07/03/2002EP1218348A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
07/03/2002EP1218347A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions
07/03/2002EP1218346A1 Pyrazole derivatives
07/03/2002EP1218343A1 Pyridine carboxamide or sulfonamide derivatives and combinatorial libraries thereof
07/03/2002EP1218341A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
07/03/2002EP1218006A2 Indolyl-3-glyoxylic acid derivatives comprising therapeutically valuable properties
07/03/2002EP0860433B1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
07/03/2002EP0795548B1 Quinazoline derivatives and use thereof
07/03/2002EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines
07/03/2002CN1356998A Method of producing nitroguanidine-and nitroenamine derivatives
07/03/2002CN1356997A Thiophene-ethyl thiourea compounds and their use in treatment of HIV
07/03/2002CN1356995A Substituted benzimidazole
07/03/2002CN1356990A Bicyclic heterocycles, medicaments contg. these compounds, their use and methods for prodn. thereof
07/03/2002CN1356988A Phenoxy fluoropyrimidines
07/03/2002CN1356987A Novel benzimidazole derivatives and pharmaceutical compsns. comprising these compounds
07/03/2002CN1356983A Tri-aryl acid derivatives as PPAR receptor ligands
07/03/2002CN1356981A Pharmaceutical compounds
07/03/2002CN1356913A Vitronectic receptor antagonist pharmaceuticals
07/03/2002CN1356903A Synthesis and crystallization of piperazine ring-contg. compounds
07/03/2002CN1356596A Charge transfer compound, organic light sensor containing said compoud for electronic photography and imaging device and method for electronic photography
07/03/2002CN1356318A Process for synthesizing multi-substituent pyridine derivative and dipyridine derivative from nitrile
07/02/2002USRE37781 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
07/02/2002US6414154 Tetraisoquinoline derivatives as modulators of dopamine D3 receptors
07/02/2002US6414152 Luminescent labelling material and procedures
07/02/2002US6414150 4,5-disubstituted imidazole compounds
07/02/2002US6414149 Treating diabetes, treating or preventing diabetic complications
07/02/2002US6414148 Produce antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals
07/02/2002US6414145 Imidazolyl compounds as inhibitors of farnesyl-protein tranferase
07/02/2002US6414012 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof
07/02/2002US6414009 Cardiovascular disorders; anticoagulants
07/02/2002US6414008 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions
07/02/2002US6413992 Insecticides, miticides
07/02/2002US6413991 Antidiabetic agents; dietetics
07/02/2002US6413990 Antiinflammatory agents, antiallergens
07/02/2002US6413987 Dermal anesthetic agents
07/02/2002US6413985 Selective antagonists for the strychnine insensitive glycine binding site associated with the nmda receptor complex.
07/02/2002US6413984 8-(heterocyclylmethyl)quinoline derivatives for treating urinary incontinence
07/02/2002US6413982 4-substituted quinoline derivatives
07/02/2002US6413969 Gatifloxacin pentahydrate
07/02/2002US6413966 Serotonergic and central dopaminergic activity; affinity for 5ht1a and 5ht2 serotonin and d2 dopamine receptors; atypical antipsychotics; schizophrenia
07/02/2002US6413960 Substituted pyrazolyl benzenesulfonamides for the treatment of asthma
07/02/2002US6413959 Neurokinin(tachykinin) antagonists
07/02/2002US6413957 Methods of inhibiting cell proliferation using indeno [1,2-c]pyrazol-4-ones
07/02/2002US6413956 Substituted 4-oxo-quinoline-3-carboxamides
07/02/2002CA2253080C 5-substituted picolinic acid compounds and their production process
07/02/2002CA2194984C 4-indole derivatives as serotonin agonists and antagonists
07/02/2002CA2065846C Quinolone carboxylic acid derivatives
06/2002
06/27/2002WO2002050072A1 Dichloropyridine carbamides
06/27/2002WO2002050068A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
06/27/2002WO2002050067A2 Pharmaceutical heterocyclic compounds
06/27/2002WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors
06/27/2002WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors
06/27/2002WO2002050062A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
06/27/2002WO2002050061A1 Piperazine derivatives for treatment of bacterial infections
06/27/2002WO2002050060A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
06/27/2002WO2002050059A1 Azinyl sulfonylimidazoles for use as microbicidal agents
06/27/2002WO2002050058A1 Crystal forms of 6-[(4-chloro-phenyl) -hydroxy-(-3-methyl- 3h-imidaol-4-yl) -methyl] -4-(3-ethynyl-phenyl) -1-methyl-1h- quinolin-2-one, 2,3- dihydroxybutanedioate salts and method of production
06/27/2002WO2002050057A1 Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders
06/27/2002WO2002050056A1 Benzylamine derivatives and their use as thrombin inhibitors
06/27/2002WO2002050045A1 Antiviral agents
06/27/2002WO2002050040A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
06/27/2002WO2002050033A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
06/27/2002WO2002050032A1 Naphthalene derivatives which bind to the ep4 receptor
06/27/2002WO2002049993A2 High affinity small molecule c5a receptor modulators
06/27/2002WO2002049648A1 Heteroaryl urea neuropeptide y y5 receptor antagonists
06/27/2002WO2002022602A3 Triazole compounds useful as protein kinase inhibitors
06/27/2002WO2002022592A3 Substituted urea neuropeptide y y5 receptor antagonists
06/27/2002WO2002020501A3 Polyarylcarboxamides useful as lipid lowering agents
06/27/2002WO2002010154A3 Substituted heterocyclic amides
06/27/2002WO2002009648A3 Antimicrobial biaryl compounds
06/27/2002WO2002008201A3 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4
06/27/2002WO2001095856A3 Urea derivative useful as an anti-cancer agent and process for preparing same
06/27/2002WO2001076600A3 Inhibition of cytokine generation
06/27/2002US20020082426 Protease inhibitors
06/27/2002US20020082282 Mutual prodrug of amlodipine and atorvastatin
06/27/2002US20020082280 Method of inhibiting neoplastic cells with benzimidazole derivatives
06/27/2002US20020082278 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases
06/27/2002US20020082274 Preparation of sodium-hydrogen exchanger type-1 inhibitors
06/27/2002US20020082272 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
06/27/2002US20020082268 Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof
06/27/2002US20020082263 Non-thiazolidinedione PPARgamma agonists; useful in modulation of blood glucose and the increase of insulin sensitivity in mammals
06/27/2002US20020082262 Regulate the cellular transport proteins P- glycoprotein and MRP1 , which are the proteins believed to be responsible for multidrug resistance in cancer patients
06/27/2002US20020082260 Isoindolin-1-one-substituted propionamide glucokinase activators which increase insulin secretion in the treatment of type II diabetes
06/27/2002US20020082259 Triazine compounds
06/27/2002US20020082257 Elevates ATP binding cassette transporter 1 expression thereby increasing efflux of cholesterol from cells by active transfer into high density lipoproteins
06/27/2002US20020082256 Compounds useful as anti-inflammatory agents
06/27/2002US20020082255 Substituted ureas
06/27/2002US20020082250 Beta lactams as antiproliferative agents
06/27/2002DE10063868A1 Dichlorpyridincarbamide Dichlorpyridincarbamide
06/27/2002CA2431995A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
06/27/2002CA2431985A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use